Quadax Industry News Bulletin
Keeping you in the know on the world of medical billing and reimbursement, this issue brings you a digest of stories impacting the lab industry.
;)For Laboratories
Pursue LDT Revenue Cycle Success with Cross-functional Collaboration
In many traditional lab organizations, the scientific product development group has historically produced new diagnostic tests without meaningful input and consideration of payer policy and revenue cycle demands. But what if the lab were to begin considering the needs of the revenue cycle even earlier? What if revenue cycle considerations were included in the lab’s decision-making […]
Quadax Presents Strategic Considerations for Managing the Increasing Patient Cost-Share Trend
CLEVELAND, January 14, 2019 – Quadax Inc., a healthcare information technology leader in providing revenue cycle optimization software and services, will present strategies for laboratories to improve collections and reduce administrative burden at the 14th Semi-Annual Q1 Diagnostic Coverage & Reimbursement Conference West. The conference takes place at the Hilton Garden Inn San Diego Bayside from […]
FASB ASC 606: Prepare Your Laboratory for a Successful Transition
This white paper is to help clinical laboratory companies successfully implement the new revenue recognition accounting standard – FASB ASC 606.
Cross-functional Collaboration is Key to Diagnostic Test Commercialization
This white paper is to help organizations that provide and develop diagnostic lab tests understand the need for strong cross-functional collaboration between the revenue cycle and the lab prior to commercialization.
On-Demand Webinar – ASC 606: Lessons Learned and What You Need to Know
This webinar reviews the principles-based guidelines of ASC 606 and highlights the potential impact within the healthcare industry.
Mitigate Prior Authorization Challenges: A Guide to Best Practices
This white paper will provide a guide to implementing a successful prior authorization strategy for clinical laboratories.
14 Day Rule Regarding ADLT and MolPath Tests Continues to Show Movement
Movement continues on CMS reimbursement of Advanced Diagnostic Laboratory Tests (ADLTs) and Molecular Pathology testing during the 14 days following a hospital stay. Recently it was announced that CMS will exercise enforcement discretion until January 2, 2019, for the laboratory date of service (DOS) exception policy for ADLTs and molecular pathology tests excluded from Hospital Outpatient […]
Quadax Introduces Prior Authorization Management Service to Streamline the Authorization Process for Labs
CLEVELAND, Aug. 7, 2018 – At this year’s 2018 Next Generation Dx Summit taking place at the Grand Hyatt Washington from August 20-24, 2018, Quadax will introduce its Prior Authorization Management Service to help laboratory departments streamline the authorization process to grow revenue, decrease claim denials, reduce administrative costs and gain visibility into operational and financial performance. @QuadaxInc […]
Prior Authorization – The Lab’s Dilemma
How are some of the payers’ Prior Authorization (PA) programs impacting your laboratory’s bottom line and what can you do about it? Increasingly, retroactive authorization after performing lab tests is becoming a less viable option; as is fighting denials for lack of Prior Authorization during the appeal process. While some payers still allow retroactive authorization, […]